WO2004099219A2 - Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations - Google Patents
Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations Download PDFInfo
- Publication number
- WO2004099219A2 WO2004099219A2 PCT/FR2004/001030 FR2004001030W WO2004099219A2 WO 2004099219 A2 WO2004099219 A2 WO 2004099219A2 FR 2004001030 W FR2004001030 W FR 2004001030W WO 2004099219 A2 WO2004099219 A2 WO 2004099219A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- silanyl
- compound
- solid support
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 76
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- -1 Silanyl Chemical group 0.000 title claims description 13
- 239000007787 solid Substances 0.000 claims abstract description 41
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 19
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 14
- 239000013545 self-assembled monolayer Substances 0.000 claims description 17
- 230000006870 function Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 150000001299 aldehydes Chemical group 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 9
- 239000003638 chemical reducing agent Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000002094 self assembled monolayer Substances 0.000 claims description 7
- 239000002356 single layer Substances 0.000 claims description 7
- YOEOBPUCCSQUAJ-UHFFFAOYSA-N 11-silylundecanal Chemical compound [SiH3]CCCCCCCCCCC=O YOEOBPUCCSQUAJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- PYQDABSJFOTHKA-UHFFFAOYSA-N 18-silyloctadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCCCC=O PYQDABSJFOTHKA-UHFFFAOYSA-N 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 3
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000003100 immobilizing effect Effects 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 claims description 3
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 3
- LESORDGPBBFSQA-UHFFFAOYSA-N 10-silyldecanal Chemical compound [SiH3]CCCCCCCCCC=O LESORDGPBBFSQA-UHFFFAOYSA-N 0.000 claims description 2
- MSQCDNIAJSTNMC-UHFFFAOYSA-N 12-silyldodecanal Chemical compound [SiH3]CCCCCCCCCCCC=O MSQCDNIAJSTNMC-UHFFFAOYSA-N 0.000 claims description 2
- QQDKIXPJMJWCGN-UHFFFAOYSA-N 14-silyltetradecanal Chemical compound [SiH3]CCCCCCCCCCCCCC=O QQDKIXPJMJWCGN-UHFFFAOYSA-N 0.000 claims description 2
- ZCDLTCBPSSOIEL-UHFFFAOYSA-N 15-silylpentadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCC=O ZCDLTCBPSSOIEL-UHFFFAOYSA-N 0.000 claims description 2
- MCFZNJMZWWQEFV-UHFFFAOYSA-N 16-silylhexadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCC=O MCFZNJMZWWQEFV-UHFFFAOYSA-N 0.000 claims description 2
- JVZLQZNKYCCMGM-UHFFFAOYSA-N 19-silylnonadecanal Chemical compound [SiH3]CCCCCCCCCCCCCCCCCCC=O JVZLQZNKYCCMGM-UHFFFAOYSA-N 0.000 claims description 2
- VTPJIHYYQGAMRN-UHFFFAOYSA-N 8-silyloctanal Chemical compound [SiH3]CCCCCCCC=O VTPJIHYYQGAMRN-UHFFFAOYSA-N 0.000 claims description 2
- VMXOLNNZQQTFID-UHFFFAOYSA-N 9-silylnonanal Chemical compound [SiH3]CCCCCCCCC=O VMXOLNNZQQTFID-UHFFFAOYSA-N 0.000 claims description 2
- HTPHIGXFDBKJGN-UHFFFAOYSA-N [SiH3]CCCCCCCCCCCCC=O Chemical compound [SiH3]CCCCCCCCCCCCC=O HTPHIGXFDBKJGN-UHFFFAOYSA-N 0.000 claims description 2
- OFJHBJKUTGALSC-UHFFFAOYSA-N [SiH3]CCCCCCCCCCCCCCCCC=O Chemical compound [SiH3]CCCCCCCCCCCCCCCCC=O OFJHBJKUTGALSC-UHFFFAOYSA-N 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 150000001408 amides Chemical group 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229910052710 silicon Inorganic materials 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 239000007822 coupling agent Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 150000004756 silanes Chemical class 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 150000001282 organosilanes Chemical class 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- LAJPMLLRVZLZTO-UHFFFAOYSA-N 11,11-dimethoxyundecyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)CCCCCCCCCCC(OC)OC LAJPMLLRVZLZTO-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004630 atomic force microscopy Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 150000003961 organosilicon compounds Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 2
- PANBRUWVURLWGY-UHFFFAOYSA-N 2-undecenal Chemical compound CCCCCCCCC=CC=O PANBRUWVURLWGY-UHFFFAOYSA-N 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N CC1CCCC1 Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 229910003828 SiH3 Inorganic materials 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000005102 attenuated total reflection Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000012844 infrared spectroscopy analysis Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- OLRJXMHANKMLTD-UHFFFAOYSA-N silyl Chemical compound [SiH3] OLRJXMHANKMLTD-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000005052 trichlorosilane Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0896—Compounds with a Si-H linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Definitions
- the present invention relates to ⁇ -silanyl-n alkanals compounds, to their preparation process, to their use for the functionalization of solid supports, to the solid supports functionalized by these compounds, as well as to the use of solid supports as well functionalized for immobilization and / or synthesis of biological molecules of interest.
- the synthetic scheme for grafting oligonucleotide molecules onto a solid support presupposes the pretreatment of surfaces (generally oxides or metals) with a coupling agent with a functional termination which is organized on the surface of the material.
- SAMs Self-assembled monolayers
- Self-Assembled Monolayers are defined as an assembly of molecules in which the molecules are organized, organization due to interactions between the chains of the molecules, giving rise to a stable anisotropic film, monomolecular and ordered (A. ULMAN, Chem. Rev., 1996, 96, 1533-1554). These self-assembled monolayers, which can be obtained in a reproducible manner (J.B. BROZSKA et al.
- organosilicon compounds have therefore already been used as coupling agents for the functionalization of solid supports (LA CHRISEY et al., Nucleic Acids Research, 1996, 24, 15, 3031-3039, U. MASKOS et al, Nucleic Acids Research, 1992 , 20, 1, 1679-1684) for the purpose of immobilizing or in situ synthesizing oligonucleotides.
- the organosilicon coupling agents used in this work form inhomogeneous films and very little resistant to subsequent chemical treatments of synthesis or immobilization of oligonucleotides.
- the formation of films with these coupling agents is not reproducible.
- the properties of the silane coupling agent depend on the nature of the organic group R, but they mainly depend on the method of attachment to the surface by means of X functions.
- the polyfunctional silanes of RSiX 3 and R 2 type SiX that is to say comprising three or two bonding functions, not only cling to the surface of the solid support but can also react with one another to form a crosslinked layer.
- the monofunctional silanes of type R 3 SiX that is to say comprising only one hooking function, only hang individually on the substrate.
- organosilanes RSiX 3 and R 3 SiX have been the most studied in the literature, both from an academic and industrial point of view, the first because they lead to the formation of a three-dimensional network and the second because they allow know the number of silanol sites present on the surface.
- the functions generally studied are the Si-Ci, Si-OMe, Si-OEt bonds and a classic example of surface modification with a trichlorosilane is given in Scheme A below: step 1
- the inventors have in fact set themselves the aim of improving the fixing qualities of the surfaces currently used to effect the immobilization of biological molecules of interest and their resistance over time, by controlling the attachment functions and have developed new silane-type compounds meeting this objective.
- the present invention therefore relates to ⁇ -silanyl-n alkanals compounds, characterized in that they correspond to the following formula (I):
- n represents an integer between 7 and 20 inclusive and preferably between 1 1 and 18 inclusive.
- These compounds are characterized by the fact that they comprise a terminal aldehyde function allowing the direct grafting of any chemical or biological molecule comprising a terminal amine function unlike all the compounds of the silane type currently available which require either a modification step (of activation) of the terminal chemical function of the silane after the grafting step on the surface of a support, ie the presence of an intermediate molecule such as glutaraldehyde for example in order to allow grafting.
- an intermediate molecule such as glutaraldehyde for example in order to allow grafting.
- the synthesis of these compounds requires special conditions which are developed below and which allow the integrity of the aldehyde function to be preserved.
- the inventors have demonstrated that the compounds of formula (I) in accordance with the invention make it possible to functionalize the surface of solid supports comprising hydroxyl functions, and this in a single step, and lead to the formation of self-assembled monolayers whose density is maximum, unlike SAMs formed from organosilanes known from the prior art, for example the compounds of formula R- (CH 3 ) 2 Si-X generally used. Indeed, if we compare the steric hindrance of different silanes, the presence of hydrogen atoms bonded to silicon leads to the minimum possible space between two silane chains, as we can see in Diagram B ci - after:
- the subject of the invention is also the process for preparing the compounds of formula (I) as defined above, characterized in that:
- n is a number between 7 and 20 inclusive in solution in an alcoholic solvent, with ethyl orthoformate, at reflux and in the presence of a catalyst to obtain a compound of formula (III) below:
- the term "mild" reducing agent is understood to mean any reducing agent capable of reducing the ethoxy groups carried by the silicon atom, thereby reducing the methoxy groups present in the compound of formula (IV). It is the judicious choice of this particular reducing agent which allows the synthesis of the compounds of formula (I) which directly comprise a terminal aldehyde function.
- certain weakly reducing agents such as sodium borohydride are not capable of reducing the ethoxy groups carried by the compounds of formula (IV) while more strongly reducing agents such as lithium trihydroaluminate not only lead to reduction ethoxy groups but also to that of the methoxy groups of the compounds of formula (IV) thus prohibiting the subsequent formation of the aldehyde function during the fourth step.
- the intermediate compounds of formulas (II) to (V), and the final compound of formula (I) at the end of the synthesis are preferably washed, isolated and purified according to the methods conventionally used for this purpose. .
- the organic solvents used during the first step are preferably chosen from lower alcohols such as methanol and ethanol.
- the reaction is preferably carried out at the reflux temperature of the solvent and the duration of the reaction is generally between 8 and 16 hours.
- the catalyst used during the first step is preferably para-toluenesulfonic acid used in a catalytic amount, that is to say at about 0.5%.
- the catalyst used during the second step is preferably chosen from catalysts based on transition metal in homogeneous phase; Karstet's catalyst being particularly preferred.
- the anhydrous solvent is preferably chosen from ethers and cyclic oxides; ethyl ether being particularly preferred.
- the "mild" reducing agent is preferably lithium tetrahydroaluminate.
- the organic solvent used during the fourth is preferably chosen from chlorinated solvents; chloroform being particularly preferred.
- the oxidizing agent is preferably chosen from strong carboxylic or mineral acids; trifluoroacetic acid (TFA) being particularly preferred.
- TFA trifluoroacetic acid
- the compounds of formula (I) in accordance with the invention can be used to form a self-assembled monolayer organized on the surface of a solid support.
- the subject of the present invention is also the use of at least one compound of formula (I) as described above to form, on the surface of a solid support comprising hydroxyl functions, a self-assembled organized monolayer.
- SAMs can be carried out conventionally for a person skilled in the art by bringing at least one hydroxylated surface of a solid support into contact with a solution of at least one compound of formula (I) in accordance with l 'Invention in an organic solvent such as for example trichlorethylene at a temperature between 2 and 10 ° C for about 12 to 24 hours.
- organic solvent such as for example trichlorethylene
- the substrate is then rinsed with different solvents, preferably and successively with trichlorethylene, ethanol, chloroform, pentane, then dried, preferably with nitrogen.
- the surfaces thus obtained directly present a large number of aldehyde functions making it possible to covalently immobilize biological molecules of interest comprising a complementary amine function, without the need for prior activation of the support.
- the compounds grafted onto the support give rise to strong covalent bonds, of the siloxane type, with the surface and develop a strong cohesion between their alkyl chains, result of a self-assembly of the molecules which protects the siloxane bonds.
- the grafting is reproducible and the aldehyde function of the grafted compounds has a high chemical reactivity.
- the roughness of the surfaces, measured by atomic force microscopy (AFM), of the support treated by thermal oxidation and after covalent coupling of the compounds of formula (I) in accordance with the invention are respectively 0.8 ⁇ and 2.3 ⁇ , which indicates the deposition of a homogeneous layer.
- the thickness of the layer measured by ellipsometry after grafting an SAM with a compound of formula (I) in which n 11 is 19.9 ⁇ 2.6 ⁇ (for a refractive index equal to 1.45), while the theoretical value for a Cn carbon chain orthogonal to the surface is 18.15 ⁇ .
- the by-product of the grafting reaction of the compounds of formula (I) in accordance with the invention on the hydroxylated surface of a solid support is a release of hydrogen, easy to remove, unlike anionic entities or protic compounds which are inherent in the processes of the prior art using chlorosilanes or alkoxysilanes.
- the grafting reaction leads to the substitution of a single Si-H bond, that is to say that the compound of formula (I) in accordance with the invention behaves like a monofunctional organosilane.
- the activation of the Si-H bonds corresponds to the organization of the long alkyl chains in the vicinity of the surface, which can allow the transient formation of hypercoordinated species of silicon, of the type [R-SiH 4 ] " or [ R-SiH 5 ] 2 " , known to be more reactive than tetrahedral species.
- IR-RTA makes it possible to identify the presence on the surface of only RSiH -O- entities, showing that there was only monofixation.
- the present invention also relates to a solid support of which at least one surface is modified by an organized self-assembled monolayer, characterized in that said monolayer comprises a network of at least one compound of formula (I) as defined above.
- network is understood to mean an assembly of molecules in which the molecules are organized and in which the chains of the molecules interact with one another by non-covalent bonds (Van der Waals forces for example).
- All the solid supports comprising at least one hydrated surface can be functionalized with the compounds of formula (I) in accordance with the invention.
- said solid support is such that its surface has, before being modified, hydroxyl groups. It is advantageously selected from the group consisting of glasses, oxide type ceramics and plastics.
- said monolayer in addition to compounds of general formula (I) according to the present invention, can also comprise any other type of compound capable of being grafted onto the solid support (obtaining a so-called “mixed” monolayer) , which makes it possible to reduce the density of the compounds of formula (I) on the support, when such an effect is sought.
- the solid supports whose surface is modified by a self-assembled monolayer organized according to the present invention can advantageously be used, as supports for the synthesis or the covalent immobilization of biological or chemical molecules of interest comprising an amino function.
- biological or chemical molecules of interest comprising an amino function.
- nucleic acids such as DNA and oligonucleotides, proteins, cellular ligands, therapeutic target molecules and combinatorial chemistry ligands.
- the subject of the present invention is also the use of a solid support as described above for the synthesis or immobilization of molecules by covalent bond (formation of an amide bond).
- the present invention also relates to a process for synthesizing molecules on a solid support as described above, characterized in that said molecules consist of a series of repeating units and in that said process comprises successive steps for grafting said repeating units, the first grafting repeating unit carrying an amine function reactive with respect to the aldehyde functions of the compounds of formula (I) in accordance with the invention present on the solid support.
- the present invention further relates to a method of immobilizing biomolecules on a solid support as described above, characterized in that it comprises a step of grafting said biomolecules, which carry reactive amino functions vis- with respect to the aldehyde functions of the compounds of formula (I) in accordance with the invention, on said solid support.
- the subject of the invention is also the solid supports as described above on which biological molecules are immobilized or chemically covalently via an amide function (nucleic acid chips, protein chips, cell ligand chips, etc.).
- the invention also comprises other arrangements which will emerge from the description which follows, which refers to an example of preparation of a compound of formula (I) according to the invention, to an example for functionalizing the surface of a solid support using a compound of formula (I), to an example of the use of a support functionalized with a compound of formula (I) for the manufacture of a chip DNA, as well as in Figures 1 and 2 attached, in which: - Figure 1 shows the image of the fluorescence obtained on an epifluorescence microscope, after grafting of the 1 1 -silanyl-undecanal on the surface of a support silicon, an oligonucleotide (manually deposited) and hybridization with a complementary target;
- FIG. 2 shows the image of the fluorescence obtained on a scanner, after grafting of the 1 1 -silanyl-undecanal on the surface of a silicon support, of an oligonucleotide (deposited in the robot) and hybridization with a complementary target.
- the hydroxylation of a silicon substrate covered with a 5000 ⁇ thermal oxide layer is carried out in a 3.5 M sodium hydroxide solution for 2 hours.
- a solid support is obtained in accordance with the invention comprising a surface modified by a self-assembled monolayer formed from 1 1 -silanyl-undecanal.
- Example 2 the modified solid support prepared above is used in Example 2.
- oligonucleotides of the following sequence: 3 'ATG TCA CAT GCC AAA TAG 5' (SEQ ID No. 1) modified in position 5 'by an amine function are carried out on the modified solid support of the example 2, either manually at the rate of 1.5 ⁇ l, or using a piezoelectric ejection robot sold under the name Nano-Plotter® by the company GeSiM (Germany), at the rate of 300 ⁇ l.
- the oligonucleotide concentration of the solution used is 10 ⁇ M in a 0.3 M Na PO 4 buffer.
- the substrates are hybridized with a solution of complementary targets of the following sequence: 3 ′ TAG AGT GTA CGG TTT ATC 5 ′ of concentration 0.1 ⁇ M, marked with a fluorescent group Cy3.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006505821A JP4781261B2 (ja) | 2003-04-30 | 2004-04-28 | シラニル−n−アルカナール化合物、その製造方法及びその使用 |
US10/554,742 US7442823B2 (en) | 2003-04-30 | 2004-04-28 | Silanyl-n-alkanal compounds, method for production and use thereof |
EP04742596A EP1626977A2 (fr) | 2003-04-30 | 2004-04-28 | Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR03/05391 | 2003-04-30 | ||
FR0305391A FR2854400B1 (fr) | 2003-04-30 | 2003-04-30 | COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004099219A2 true WO2004099219A2 (fr) | 2004-11-18 |
WO2004099219A3 WO2004099219A3 (fr) | 2005-12-01 |
Family
ID=33155602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2004/001030 WO2004099219A2 (fr) | 2003-04-30 | 2004-04-28 | Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations |
Country Status (5)
Country | Link |
---|---|
US (1) | US7442823B2 (fr) |
EP (1) | EP1626977A2 (fr) |
JP (1) | JP4781261B2 (fr) |
FR (1) | FR2854400B1 (fr) |
WO (1) | WO2004099219A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102428145B (zh) * | 2009-03-18 | 2014-03-26 | 巴斯夫欧洲公司 | 改性的二氧化硅粒子和包含它们的防污聚合物组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051856A2 (fr) * | 2000-12-22 | 2002-07-04 | Commissariat A L'energie Atomique | Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques |
-
2003
- 2003-04-30 FR FR0305391A patent/FR2854400B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-28 EP EP04742596A patent/EP1626977A2/fr not_active Withdrawn
- 2004-04-28 JP JP2006505821A patent/JP4781261B2/ja not_active Expired - Fee Related
- 2004-04-28 US US10/554,742 patent/US7442823B2/en not_active Expired - Fee Related
- 2004-04-28 WO PCT/FR2004/001030 patent/WO2004099219A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051856A2 (fr) * | 2000-12-22 | 2002-07-04 | Commissariat A L'energie Atomique | Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques |
Non-Patent Citations (3)
Title |
---|
CHRISEY L A ET AL: "Covalent attachment of synthetic DNA to self-assembled monolayer films" NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 24, no. 15, 1996, pages 3031-3039, XP002149193 ISSN: 0305-1048 cité dans la demande * |
DATABASE REGISTRY XP002273087 * |
MASKOS U ET AL: "OLIGNUCLEOTIDE HYBRIDISATIONS ON GLASS SUPPORTS: A NOVEL LINKER FOROLIGONUCLEOTIDE SYNTHESIS AND HYBRIDISATION PROPERTIES OF OLIGNUCLEOTIDES SYNTHESISED IN SITU" NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 20, no. 7, 1992, pages 1679-1684, XP000651031 ISSN: 0305-1048 cité dans la demande * |
Also Published As
Publication number | Publication date |
---|---|
US20070032672A1 (en) | 2007-02-08 |
FR2854400B1 (fr) | 2007-04-20 |
WO2004099219A3 (fr) | 2005-12-01 |
FR2854400A1 (fr) | 2004-11-05 |
EP1626977A2 (fr) | 2006-02-22 |
JP2006525979A (ja) | 2006-11-16 |
US7442823B2 (en) | 2008-10-28 |
JP4781261B2 (ja) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1607743B1 (fr) | Silanes avec des fonctionalités pre-activées et résistante aux protéines et des films comprenant ces silanes | |
US5686548A (en) | Polymers useful in forming self-assembled bonded anisotropic ultrathin layers and their use | |
Haensch et al. | Chemical modification of self-assembled silane based monolayers by surface reactions | |
EP1979362B1 (fr) | Nouveaux composés silanes et leur utilisation pour fonctionnaliser des supports solides et immobiliser sur ces supports des molécules biologiques | |
US5858544A (en) | Spherosiloxane coatings | |
US8067065B2 (en) | Fibrillar, nanotextured coating and method for its manufacture | |
US9296870B2 (en) | Modification of surfaces with nanoparticles | |
JP2003321479A (ja) | 光分解性シランカップリング剤 | |
JP4233283B2 (ja) | 生体物質固定用基板及びその製造方法 | |
WO2001086301A1 (fr) | Composition polymère pour former la surface d'un biocapteur | |
CA2453303C (fr) | Procede de fonctionnalisation de supports solides | |
WO2004005410A1 (fr) | Support solide comportant une surface conductrice ou semi-conductrice de l'electricite fonctionnalisee, son procede de preparation et ses utilisations | |
WO2004099219A2 (fr) | Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations | |
EP1248789B1 (fr) | Composes organosilicies, leur procede de preparation et leurs utilisations | |
EP1525210B1 (fr) | Procede de fabrication de puces biologiques | |
US11332588B2 (en) | Process for modification of a solid surface | |
EP1979363B1 (fr) | Nouveaux composés silanes et leur utilisation pour fonctionnaliser des supports solides et immobiliser sur ces supports des molécules biologiques | |
EP1248859B1 (fr) | Procedes de synthese et d'immobilisation d'acides nucleiques sur un support solide silanise | |
JP2006143715A (ja) | 新規のリンカー化合物、該化合物がコーティングされている基板、該化合物を利用してマイクロアレイを製造する方法、及びそれによって製造されたマイクロアレイ | |
JPH07188259A (ja) | シランとその使用方法 | |
KR20090026060A (ko) | 다기능성 고분자막 및 그의 용도 | |
EP2027133B1 (fr) | Nouveaux composes silanes porteurs d'une fonction hydrazone ou diazo pour fonctionnaliser des supports solides et immobiliser sur ces supports des molecules biologiques | |
Yousefalhaj | Molecular engineering of azidoorganosilane-based SAMs for bioapplications | |
WO2003101905A1 (fr) | Procede pour l'elaboration d'un substrat mineral modifie en surface, et substrat obtenu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006505821 Country of ref document: JP |
|
REEP | Request for entry into the european phase |
Ref document number: 2004742596 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004742596 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004742596 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007032672 Country of ref document: US Ref document number: 10554742 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10554742 Country of ref document: US |